NCT00001507View on ClinicalTrials.gov

Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

July 12, 1996

Primary Completion Date

June 30, 1998

Study Completion Date

June 20, 2014

Conditions
Breast NeoplasmNeoplasm Metastasis
Interventions
DRUG

Monoclonal Antibody 3A1

DRUG

Monoclonal Antibody 95-5-49

DRUG

Monoclonal Antibody 95-6-22

DEVICE

Baxter Isolex 3001 Stem Cell Selection System

DEVICE

Ceprate SC

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00001507 - Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast Cancer | Biotech Hunter | Biotech Hunter